The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)
Bartosz Wasąg(Gdańsk Medical University), Peter Vandenberghe(KU Leuven)
Cited by 61
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis
|Journal of Clinical Microbiology|1999|376
Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients
|Human Mutation|2015|18
Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations
|Diagnostic Pathology|2015|7